Skip to search formSkip to main contentSkip to account menu

Benign Ovarian Neoplasm

Known as: benign ovarian tumors, Benign Tumor of Ovary, Benign Neoplasm of the Ovary 
A non-metastasizing neoplasm that arises from the ovary. Representative examples include serous cystadenoma, mucinous cystadenoma, clear cell… 
National Institutes of Health

Related topics

Related topics

14 relations
Adenocarcinoma Cell with Intracytoplasmic MucinBenign NeoplasmBrenner TumorFemale Reproductive System

Broader (4)

Female Reproductive System DisorderNeoplasm, uncertain whether benign or malignantNeoplasmsOvarian Cysts

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Integrated extracellular microRNA profiling for ovarian cancer screening
A major obstacle to improving prognoses in ovarian cancer is the lack of effective screening methods for early detection… 
Highly Cited
2011
Highly Cited
2011
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
OBJECTIVE: To compare the effectiveness of physician assessment with a new multivariate index assay in identifying high-risk… 
Review
2009
Review
2009
Laparoscopy versus laparotomy for benign ovarian tumour.
BACKGROUND Over the last 10 years laparoscopy and minilaparotomy have become increasingly common approaches for the surgical… 
Highly Cited
2008
Highly Cited
2008
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
PurposeInflammatory cells can both suppress and stimulate tumor growth, and the influence of inflammatory cells on clinical… 
Highly Cited
2007
Highly Cited
2007
Expression of CD133-1 and CD133-2 in ovarian cancer
Cancer stem cells have been isolated from several solid tumors including prostate, colon, liver, breast, and ovarian cancer. Stem… 
Highly Cited
2001
Highly Cited
2001
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Proteases are linked to the malignant phenotype of different solid tumors. Therefore, the expression of the matrix… 
Highly Cited
2001
Highly Cited
2001
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
This study investigates whether and to what extent cyclooxygenase type-2 (COX-2) and inducible nitric oxide-synthase (iNOS), both… 
Review
2001
Review
2001
Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings.
OBJECTIVE Our study evaluated the diagnostic performance of MR imaging compared with that of transvaginal sonography and positron… 
Highly Cited
1994
Highly Cited
1994
Overexpression of the MET/HGF receptor in ovarian cancer
The MET oncogene encodes the receptor for Hepatocyte Growth Factor/Scatter Factor, a unique growth factor that induces not only… 
Highly Cited
1990
Highly Cited
1990
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.
The F19 antigen is a cell surface glycoprotein (Mr, 95,000) of human sarcomas and proliferating, cultured fibroblasts that is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)